Insider Trading & Ownership of Sands Capital Life Sciences Pulse Fund II, L.P.

Location
Arlington, VA
Summary
The estimated value of insider holdings of Sands Capital Life Sciences Pulse Fund II, L.P. is at least $18,877,499 dollars as of 24 Nov 2025. Sands Capital Life Sciences Pulse Fund II, L.P. is the 10%+ Owner of Inhibikase Therapeutics, Inc. and owns shares of Inhibikase Therapeutics, Inc. (IKT) stock worth about $18.88M.
Signature
Sands Capital Life Sciences Pulse Fund II, L.P., By: Sands Capital Life Sciences Pulse Fund II-GP, L.P., its General Partner, By: Sands Capital Life Sciences Pulse Fund II-GP, LLC, its General Partner, By: /s/ Jonathan Goodman, General Counsel
All Insider Reports
All Insider Reports

Notify me when Sands Capital Life Sciences Pulse Fund II, L.P. files a new Insider Trading report.

⭐ Subscribe ⭐

Ownership of Sands Capital Life Sciences Pulse Fund II, L.P.

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
IKT Inhibikase Therapeutics, Inc. 10%+ Owner $18,877,499 +$2,999,999 +19% 21 Nov 2025

Insider Transactions Reported by Sands Capital Life Sciences Pulse Fund II, L.P.:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.